Thromb Haemost 1985; 54(02): 397-401
DOI: 10.1055/s-0038-1657748
Original Article
Schattauer GmbH Stuttgart

Interaction of β2-Glycoprotein-I with Human Blood Platelets: Influence Upon the ADP-Induced Aggregation

Johannes Nimpf
*   The Physiological Institute, University of Graz, Austria
,
Helmut Wurm
*   The Physiological Institute, University of Graz, Austria
,
Gerhard M Kostner
**   The Institute of Medical Biochemistry, University of Graz, Austria
› Author Affiliations
Further Information

Publication History

Received 11 January 1985

Accepted 22 April 1985

Publication Date:
18 July 2018 (online)

Summary

The interaction of β2-glycoprotein-I (β2-G-I), a plasma constituent of unknown function, with blood platelets was studied. The following results were obtained: 1) β2-G-I binds to washed human platelets isolated by centrifugation (WP) at one kind of specific, saturable binding sites. The dissociation constant was found to be approx. 1 × 10−6M.

2) In the presence of physiological concentrations of Ca++ (2.5 mM), this specific binding is markedly reduced. Unspecific binding of β2-G-I to platelets, however, is not influenced by Ca++.

3) Platelets prepared by gel filtration (GFP), differing in their in vitro aggregability from WP, exhibit no specific binding of β2-G-I. Binding to GFP is also not induced by activation with thrombin, collagen or ADP.

4) β2-G-I causes significant alteration of the ADP-induced aggregation of GFP. Aggregation induced by thrombin, collagen, arachidonic acid or PAF-acether, however is not altered by β2G-I.

It is suggested, that pelleting during centrifugation causes irreversible rearrangements in the membrane of platelets.

 
  • References

  • 1 Heimburger N, Heide K, Haupt H. Bausteinanalyse von Human-serumproteinen. Clin Chim Acta 1964; 10: 293-307
  • 2 Schultze HE, Heide K, Haupt H. Über ein bisher unbekanntes niedermolekulares β2-Globulin des Humanserums. Naturwissenschaften 1961; 23: 719
  • 3 Cleve H, Rittner C. Further family studies on the genetic control of β2- Glycoprotein-I concentration in human serum. Humangenetik 1969; 7: 93-97
  • 4 Lee NS, Brewer HB, Osborne JC. β2-glycoprotein-I. Molecular properties of an unusual apoliprotein, apoliprotein H. J Biol Chemn 1983; 258: 4765-4770
  • 5 Polz E, Kostner GM. The binding of β2-glycoprotein-I to human serum lipoproteins. FEBS Lett 1979; 102: 183-186
  • 6 Polz E, Kostner GM. Binding of β2-glycoprotein-I to Intralipid: Determination of the dissociation constant. Biochem Biophys Res Commun 1979; 90: 1305-1312
  • 7 Nakaya Y, Schaefer EJ, Brewer HB. Activation of human post heparin lipase by apolipoprotein H (β2-glycoprotein-I). Biochem Biophys Res Commun 1980; 95: 1168-1172
  • 8 Wurm H, Beubler E, Polz E, Holasek A, Kostner GM. Studies on the possible function of β2-glycoprotein-I: Influence in the triglyceride metabolism in the rat. Metabolism 1982; 31: 484-486
  • 9 Polz E. Isolation of a specific lipid binding protein from human serum by affinity chromatography using heparin-sepharose. In Protides of Biological Fluids. Peeters H. (Ed). Pergamon Press; Oxford: 1979: 817-820
  • 10 Polz E, Wurm H, Kostner GM. Investigations on β2-glycoprotein-I in the rat: Isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem 1980; 11: 265-270
  • 11 Wurm H. β2-glycoprotein-I (apolipoprotein-I) interactions with phospholipid vesicles. Int J Biochem 1984; 16: 511-517
  • 12 Schousboe I. Purification, characterization and identification of an agglutinin in human serum. Biochim Biophys Acta 1979; 579: 396-408
  • 13 Schousboe I. Binding of β2-glycoprotein-I to platelets: Effect of adenylate cyclase activity. Thromb Res 1980; 19: 225-237
  • 14 Baenzinger NL, Majerus PW. Isolation of human platelets and surface membranes. Methods-Enzymol 31: 155-149
  • 15 Tangen O, Berman HJ, Marfey P. Gel filtration – a new technique for separation of blood platelets from plasma. Thrombos Diathes Haemorrh 1971; 25: 268-278
  • 16 Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
  • 17 McFarlane AS. Efficient trace-labelling of proteins with iodine. Nature 1958; 182: 53
  • 18 Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235-254
  • 19 Burstein M, Scholnik HR. Precipitation of chylomicrons and very low density lipoproteins from human serum with sodium lauryl sulfate. Life Sci 1972; 11: 177-184
  • 20 Ardlie NG, Perry DW, Packham MA, Mustard JF. Influence of apyrase on stability of suspensions of washed rabbit platelets. Proc Soc Exp Biol Med 1971; 136: 1021-1023
  • 21 Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-5363
  • 22 Chap HJ, Zwaal RFA, Van Deenen LLM. Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim Biophys Acta 1977; 467: 146-164
  • 23 Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66
  • 24 Rosing J, Tans G, Gowers-Riemslag JWP, Zwaal RFA, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-283
  • 25 Bevers EM, Comfurius P, Van Rijen J, Hemker HC, Zwaal RFA. Generation of prothrombinase converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-436
  • 26 Van Rijen LML, Rosing J, Van Dieijen G, Bevers EM, Zwaal RFA, Hemker HC. The interaction between blood platelets and blood coagulation factors. Arzneimittelforschung – Drug Res 1983; 33: 1365-1369